Phase I/II trial of sorafenib combined with FOLFOX4 in untreated patients with advanced gastric adenocarcinoma: Phase I results.

Yihebali Chi,Jianliang Yang,Feng Du,Sheng Yang,Yongkun Sun,Yuankai Shi

Phase I/II trial of sorafenib combined with FOLFOX4 in untreated patients with advanced gastric adenocarcinoma: Phase I results.

2017

Yihebali Chi
Jianliang Yang
Feng Du
Sheng Yang
Yongkun Sun
Yuankai Shi

e14606 Background: Sorafenib (Sor) is a potent inhibitor of multiple intracellular and cell surface kinases. FOLFOX4 was demonstrated to be an active and well-tolerated chemotherapy for advanced ga...

Keywords:

Sorafenib
Kinase
Pathology
Cancer research
Medicine
Intracellular
Cell
Adenocarcinoma
Chemotherapy
phase i ii
gastric adenocarcinoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations